| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5489436 | J AND J CONSUMER INC | Taste mask coatings for preparation of chewable pharmaceutical tablets |
Feb, 2013
(11 years ago) | |
| US5679376 | J AND J CONSUMER INC | Simethicone containing pharmaceutical compositions |
Oct, 2014
(9 years ago) | |
| US6103260 | J AND J CONSUMER INC | Simethicone/anhydrous calcium phosphate compositions |
Jul, 2017
(6 years ago) | |
Imodium Multi-Symptom Relief is owned by J And J Consumer Inc.
Imodium Multi-Symptom Relief contains Loperamide Hydrochloride; Simethicone.
Imodium Multi-Symptom Relief has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Imodium Multi-Symptom Relief are:
- US5489436
- US5679376
- US6103260
Imodium Multi-Symptom Relief was authorised for market use on 26 June, 1996.
Imodium Multi-Symptom Relief is available in tablet;oral dosage forms.
The generics of Imodium Multi-Symptom Relief are possible to be released after 17 July, 2017.
Drugs and Companies using LOPERAMIDE HYDROCHLORIDE; SIMETHICONE ingredient
Market Authorisation Date: 26 June, 1996
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of IMODIUM MULTI-SYMPTOM RELIEF before it's drug patent expiration?
More Information on Dosage
IMODIUM MULTI-SYMPTOM RELIEF family patents
